JP2014516627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014516627A5 JP2014516627A5 JP2014505357A JP2014505357A JP2014516627A5 JP 2014516627 A5 JP2014516627 A5 JP 2014516627A5 JP 2014505357 A JP2014505357 A JP 2014505357A JP 2014505357 A JP2014505357 A JP 2014505357A JP 2014516627 A5 JP2014516627 A5 JP 2014516627A5
- Authority
- JP
- Japan
- Prior art keywords
- dendrimer
- kit
- polymer
- solution
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000412 dendrimer Substances 0.000 claims 22
- 229920000736 dendritic polymer Polymers 0.000 claims 22
- 229920000642 polymer Polymers 0.000 claims 17
- 229920002307 Dextran Polymers 0.000 claims 3
- 239000000853 adhesive Substances 0.000 claims 3
- 230000001070 adhesive effect Effects 0.000 claims 3
- 125000003172 aldehyde group Chemical group 0.000 claims 3
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims 3
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 238000012377 drug delivery Methods 0.000 claims 1
- 239000004088 foaming agent Substances 0.000 claims 1
- 238000007306 functionalization reaction Methods 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- -1 pH adjusters Substances 0.000 claims 1
- 229920000962 poly(amidoamine) Polymers 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161474984P | 2011-04-13 | 2011-04-13 | |
| US61/474,984 | 2011-04-13 | ||
| PCT/US2012/033604 WO2012142470A1 (en) | 2011-04-13 | 2012-04-13 | Biocompatible adhesive materials and methods |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014516627A JP2014516627A (ja) | 2014-07-17 |
| JP2014516627A5 true JP2014516627A5 (enExample) | 2015-05-07 |
| JP5980905B2 JP5980905B2 (ja) | 2016-08-31 |
Family
ID=46026933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014505357A Active JP5980905B2 (ja) | 2011-04-13 | 2012-04-13 | 生体適合性接着剤材料及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US8802072B2 (enExample) |
| EP (1) | EP2696906B1 (enExample) |
| JP (1) | JP5980905B2 (enExample) |
| ES (1) | ES2548406T3 (enExample) |
| WO (1) | WO2012142470A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112016014439A2 (pt) * | 2013-12-23 | 2017-08-08 | Massachusetts Inst Technology | Métodos e composições degradáveis de modo controlado |
| US10780195B2 (en) | 2015-06-24 | 2020-09-22 | Massachusetts Instiitute of Technology | Controllably degradable compositions and methods |
| US9572555B1 (en) * | 2015-09-24 | 2017-02-21 | Ethicon, Inc. | Spray or drip tips having multiple outlet channels |
| US10342894B2 (en) | 2015-10-16 | 2019-07-09 | Massachusetts Institute Of Technology | Hydrogel composites, compositions, and methods |
| CA3013922A1 (en) * | 2016-02-08 | 2017-08-17 | The Johns Hopkins University | Dendrimer-bioadhesive polymer hydrogel nanoglue and use thereof |
| US11020160B2 (en) * | 2016-03-21 | 2021-06-01 | Warsaw Orthopedic, Inc. | Surgical injection system and method |
| CA3088957A1 (en) * | 2017-01-17 | 2018-07-26 | Tufts Medical Center, Inc. | Adoptive transfer of plasmacytoid dendritic cells to prevent or treat ocular diseases and conditions |
| WO2018201007A2 (en) | 2017-04-27 | 2018-11-01 | The Johns Hopkins University | Dendrimer compositions for use in angiography |
| CN111615528A (zh) | 2017-11-10 | 2020-09-01 | 约翰霍普金斯大学 | 树枝状聚合物递送系统和其使用方法 |
| US10994261B2 (en) | 2018-01-18 | 2021-05-04 | Research Triangle Institute | Polyamine phosphorus dendrimer materials for carbon dioxide capture |
| JP2021522983A (ja) * | 2018-05-15 | 2021-09-02 | バイオデヴェック インコーポレイテッドＢｉｏＤｅｖｅｋ， Ｉｎｃ． | イオン性および共有結合性相互作用を有する生体適合性接着剤 |
| CN113474300A (zh) | 2019-01-17 | 2021-10-01 | 三角研究所 | 用于金属螯合的多胺磷树枝状大分子材料 |
| IL293606A (en) | 2019-12-04 | 2022-08-01 | Ashvattha Therapeutics Inc | Dendrimer preparations and methods of administering a drug to the eye |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4768523A (en) | 1981-04-29 | 1988-09-06 | Lifecore Biomedical, Inc. | Hydrogel adhesive |
| US5306504A (en) | 1992-12-09 | 1994-04-26 | Paper Manufactures Company | Skin adhesive hydrogel, its preparation and uses |
| US20040131582A1 (en) | 2002-02-26 | 2004-07-08 | Grinstaff Mark W. | Novel dendritic polymers and their biomedical uses |
| EP1364663A1 (en) | 2002-05-21 | 2003-11-26 | Commonwealth Scientific And Industrial Research Organisation | Ocular devices with functionalized surface with adhesive properties |
| WO2006042161A2 (en) | 2004-10-07 | 2006-04-20 | E.I. Dupont De Nemours And Company | Polysaccharide-based polymer tissue adhesive for medical use |
| US8790632B2 (en) | 2004-10-07 | 2014-07-29 | Actamax Surgical Materials, Llc | Polymer-based tissue-adhesive form medical use |
| WO2007067622A2 (en) * | 2005-12-06 | 2007-06-14 | Tyco Healthcare Group Lp | Carbodiimide crosslinking of functionalized polethylene glycols |
| JP5559190B2 (ja) | 2008-11-19 | 2014-07-23 | アクタマックス サージカル マテリアルズ リミテッド ライアビリティ カンパニー | 繊維状組織シーラントおよびその使用方法 |
| ES2574238T3 (es) | 2009-07-02 | 2016-06-16 | Actamax Surgical Materials Llc | Adhesivo tisular de hidrogel para uso médico |
-
2012
- 2012-04-13 ES ES12718802.7T patent/ES2548406T3/es active Active
- 2012-04-13 US US13/446,712 patent/US8802072B2/en active Active
- 2012-04-13 WO PCT/US2012/033604 patent/WO2012142470A1/en not_active Ceased
- 2012-04-13 EP EP12718802.7A patent/EP2696906B1/en active Active
- 2012-04-13 JP JP2014505357A patent/JP5980905B2/ja active Active
-
2014
- 2014-07-30 US US14/446,805 patent/US9707313B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014516627A5 (enExample) | ||
| WO2011079279A3 (en) | Nanoconjugates and nanoconjugate formulations | |
| BR112013027674A2 (pt) | "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha". | |
| JP2014526342A5 (enExample) | ||
| GT201300235A (es) | Uso de 2,3-dihidroimidazo (1,2-c) quinazolinas sustituidas | |
| JP2013046873A5 (enExample) | ||
| WO2009155594A3 (en) | Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator | |
| UY32497A (es) | "2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso" | |
| WO2010009034A3 (en) | Method for treating atrophic age related macular degeneration | |
| JP2016014025A5 (enExample) | ||
| BR112012032979B8 (pt) | Composição para limpeza da pele límpida, de baixa irritação, e com ph relativamente baixo e método de limpeza da pele | |
| BRPI1102843B8 (pt) | Composições de limpeza límpidas, de baixa irritação com ph relativamente baixo | |
| WO2013060769A3 (en) | Hemostatic compositions | |
| MY168413A (en) | Amino-substituted imidazopyridazines | |
| ECSP13012449A (es) | Quelatos de oligonucleótidos | |
| CL2012003038A1 (es) | Polietilenglicol conjugado a factor viia; composicion farmacéutica que comprende dicho polietilenglicol conjugado a factor viia; uso de una composicion farmaceutica para tratar enfermedad o trauma de la coagulacion de la sangre en un paciente que la necesita; proceso para preparar el siguiente polietilenglicol conjugado a factor viia. | |
| TR200806298A2 (tr) | Farmasötik formülasyon | |
| MX2011004085A (es) | Factores sanguineos modificados que comprenden un bajo grado de polimero soluble en agua. | |
| WO2010059001A3 (ko) | 내성암 치료용 고분자 미셀 조성물 및 그 제조방법 | |
| BRPI0915269A2 (pt) | octonidina ou um sal farmacêutico do mesmo, kit farmacêutico, composição farmacêutica e agente farmacêutico | |
| WO2015006501A3 (en) | Microvessel endothelial cell surface markers and uses thereof | |
| PE20141189A1 (es) | Preparacion de liberacion sostenida | |
| CA2816999A1 (en) | Compositions and methods for nanopolymer-based nucleic acid delivery | |
| CL2009001083A1 (es) | Variantes de receptores de la proteina c3 de complemento (crig), molecula quimerica y composicion farmaceutica que las comprende; uso de las variantes para preparar un medicamento para prevenir o tratar una enfermedad asociada al complemento, tal como una enfermedad inflamatoria o autoinmune. | |
| WO2006094917A3 (en) | Oligodeoxyribonucleotides of 4000-10000 dalton for treating tumors |